Live Breaking News & Updates on Zyme Communications

Stay updated with breaking news from Zyme communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing

Partnership to develop and implement Cellular Origins' robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult's Stevenage Manufacturing Innovation Centre Cellular ....

Matthew Durdy , Jake Brown , Zyme Communications , Stevenage Manufacturing Innovation Centre , Cellular Origin , Stevenage Manufacturing Innovation , Gene Therapy Catapult , Cellular Origin Constellation , Good Manufacturing Practice , Edwin Stone , Cellular Origins , Chief Executive , Ihr Portfolio ,

Exonate Ltd.: Exonate Appoints Dr Rafiq Hasan as Non-Executive Director

Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens Board Exonate Ltd., a biotechnology company developing novel ....

Rafiq Hasan , Katie Odgaard , Zyme Communications , Exonate Ltd , Complement Therapeutics , Senior Vice President , Global Head , Clinical Evaluation , New Eyedrop , Alleviating Retinopathy , Diabetic Macular Oedema , Non Executive Director , Ihr Portfolio ,

Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics

Partnership expands spectrum of Secarna's capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna's antisense ....

Lily Jeffery , Konstantin Petropoulos , Orbit Discovery Ltd , Zyme Communications , Secarna Pharmaceuticals We , Secarna Pharmaceuticals Gmbh Co , Orbit Discovery , Secarna Pharmaceuticals , Neil Butt , Chief Executive Officer , Ihr Portfolio ,

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conj

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): AgreementSecarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics 28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announ. ....

United Kingdom , Alexander Gebauer , Lily Jeffery , Anne Hennecke Vera Lang , Konstantin Petropoulos , Mc Services , Zyme Communications , Orbit Discovery Ltd , Secarna Pharmaceuticals Gmbh Co , Distribution Services , Secarna Pharmaceuticals We , Professor Graham Ogg University Of Oxford , Media Enquiries For Secarna Pharmaceuticals , Secarna Pharmaceuticals , Secarna Pharmaceuticals Gmbh , Orbit Discovery , Neil Butt , Chief Executive Officer , Discovery Ltd , Oxford Science Park , Professor Graham Ogg , Professor Terry Rabbits , Cancer Research , Corporate News , Regulatory Announcements ,

Exonate Ltd.: CORRECTING and REPLACING Exonate Appoints Dr Rafiq Hasan as Non-Executive Director

EXONATE APPOINTS DR RAFIQ HASAN AS NON-EXECUTIVE DIRECTOR Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens ....

Rafiq Hasan , Katie Odgaard , Zyme Communications , Exonate Ltd , Complement Therapeutics , Senior Vice President , Global Head , Alleviating Retinopathy , Diabetic Eye , Non Executive Director , Ihr Portfolio ,